CALLAN JMB INC
CJMBNASDAQTrading Snapshot
- Day Range
- $2.39 β $2.43
- 52-Week Range
- $0.65 β $5.61
- Volume
- $1.80B
- Avg Volume
- $2.11B
- Shares Outstanding
- 4.8M
- Next Earnings
- Dec 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $6M
- Last Q Revenue
- $1M
- P/E Ratio
- -1.1
- P/S Ratio
- 2.1x
- EPS (TTM)
- $-1.73
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β26.7%
Why Investors Own CJMB
- βHigh-growth profile β revenue up -9.7% YoY with expanding US Equity exposure.
- βHealthy economics β 53% gross margin and 30% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CALLAN JMB INC
CJMBAbout CALLAN JMB INC
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
CALLAN JMB INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CJMB price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CALLAN JMB INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.